USANA Health Sciences Inc (NYSE:USNA)
| 71.54 Delayed Data As of 4:00pm ET |  +0.97 / +1.37%Today’s Change | 67.01 Today|||52-Week Range 107.85 | -29.31% Year-to-Date |
Latest USNA News | Press Releases
No recent news for USANA Health Sciences Inc.
Today’s Trading
| Previous close | 70.57 |
| Today’s open | 71.29 |
| Day’s range | 71.00 - 71.74 |
| Volume | 37,489 |
| Average volume (3 months) | 73,128 |
| Market cap | $1.3B |
Data as of 4:00pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -1.86% |
| Earnings growth (this year) | -8.03% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +4.57% |
| P/E ratio | 13.2 |
| Price/Sales | 1.74 |
| Price/Book | 3.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRONCronos Group Inc | -0.05 | -1.61% |
| ---- | ||
| ACBAurora Cannabis Inc | -1.05 | -38.28% |
| ---- |
Data as of 6:52pm ET, 05/27/2022
Financials
| Next reporting date | July 26, 2022 |
| EPS forecast (this quarter) | $1.26 |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | $116.5M |
| Net profit margin | 9.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
